EGFR monoclonal antibody (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR monoclonal antibody (unspecified), covering 2024-07-08 to 2024-07-08. Get the full timeline:
Most recent: Clinical Trial Update: Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes [Phase 2]